These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25793143)

  • 1. Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study.
    Pagonabarraga J; Piñol G; Cardozo A; Sanz P; Puente V; Otermín P; Legarda I; Delgado T; Serrano C; Balaguer E; Aguirregomozcorta M; Álvarez R; Kulisevsky JJ
    Parkinsons Dis; 2015; 2015():131508. PubMed ID: 25793143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Psychometric Characteristics of Parkinson's Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson's Disease: A Validation Study.
    Liguori C; Frontani F; Francescangeli G; Pierantozzi M; Cerroni R; Schirinzi T; Stefani A; Mercuri NB; Galeoto G
    J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
    Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
    Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
    Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
    BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study.
    Chung SJ; Kim JM; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
    Expert Opin Pharmacother; 2015 May; 16(7):961-70. PubMed ID: 25846031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature.
    Mateo-Carrasco H; Serrano-Castro PJ; Molina-Cuadrado E; Goodwin M; Nguyen TV; Kotecha PN
    Int J Clin Pharm; 2015 Aug; 37(4):559-62. PubMed ID: 25822041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?
    Rosa-Grilo M; Qamar MA; Taddei RN; Pagonabarraga J; Kulisevsky J; Sauerbier A; Chaudhuri KR
    NPJ Parkinsons Dis; 2017; 3():28. PubMed ID: 28890931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotigotine in the treatment of primary restless legs syndrome: A meta-analysis of randomized placebo-controlled trials.
    Ding J; Fan W; Chen HH; Yan P; Sun SG; Zheng J
    J Huazhong Univ Sci Technolog Med Sci; 2015 Apr; 35(2):169-175. PubMed ID: 25877347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke.
    Sami MB; Faruqui R
    Acta Neuropsychiatr; 2015 Dec; 27(6):317-26. PubMed ID: 25850757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does in utero exposure of antiepileptic drugs lead to failure to reach full cognitive potential?
    McCorry D; Bromley R
    Seizure; 2015 May; 28():51-6. PubMed ID: 25819874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus phenytoin in management of status epilepticus.
    Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
    J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
    Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of antiepileptic drugs on cognitive functional magnetic resonance imaging.
    Beltramini GC; Cendes F; Yasuda CL
    Quant Imaging Med Surg; 2015 Apr; 5(2):238-46. PubMed ID: 25853082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease.
    Vallderiola F; Compta Y; Aparicio J; Tarradellas J; Salazar G; Oliver JM; Callén A; Delgado T; Nobbe F
    Parkinsons Dis; 2015; 2015():475630. PubMed ID: 26576319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
    Pierantozzi M; Placidi F; Liguori C; Albanese M; Imbriani P; Marciani MG; Mercuri NB; Stanzione P; Stefani A
    Sleep Med; 2016 May; 21():140-4. PubMed ID: 27448485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity.
    Timmermann L; Asgharnejad M; Boroojerdi B; Dohin E; Woltering F; Elmer LW
    Expert Opin Pharmacother; 2015; 16(10):1423-33. PubMed ID: 25997442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach.
    Magalhães JC; Gongora M; Vicente R; Bittencourt J; Tanaka G; Velasques B; Teixeira S; Morato G; Basile LF; Arias-Carrión O; Pompeu FA; Cagy M; Ribeiro P
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):83-93. PubMed ID: 25912541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
    Arı H; Kahraman F; Acaban MB
    Turk Kardiyol Dern Ars; 2015 Apr; 43(3):284-7. PubMed ID: 25906002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system.
    Blundo C; Gerace C
    Neurol Sci; 2015 Jul; 36(7):1197-201. PubMed ID: 25876742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.